These results provide evidence that a CD44/Zeb1 loop is activated in vivo at sites of hypoxia and Tgf-β1 accumulation in expanding precancerous adenomas, and this loop then initiates a two-step pathway in which precancerous cells transition to cancer cells via a stable intermediate population of CGC. Here, CD44 is linked to cancer.